LMICs, where investigators implemented MMCs focusing on process issues rather than clinician-level errors.
Association of Intraoperative Radiotherapy in the Treatment of Early-Stage Breast Cancer With Minor Surgical Site Complications in Oncoplastic Breast-Conserving Surgery
Breast-conserving therapy is a standard treatment option for patients with early-stage breast cancer, as large randomized studies have demonstrated equivalent overall and disease-free survival compared with mastectomy.
1,2 Currently, breast-conserving therapy consists of surgical removal of the tumor and axillary staging followed by adjuvant whole-breast radiotherapy (WBRT). Through incorporation of plastic surgery techniques, oncoplastic breastconserving surgery (OBCS) improves oncologic outcomes while improving cosmesis and reducing rates of postoperative reexcision, complications, and mastectomy. 3, 4 Breastconserving therapy requires prolonged treatment owing to daily WBRT, which poses logistical impediments for some patients.
Intraoperative radiotherapy (IORT) has emerged as an alternative to WBRT. Intraoperative radiotherapy delivers a single intraoperative dose of radiotherapy to the tumor bed at the time of surgical resection. The Targeted Intraoperative Radiotherapy Versus Whole Breast Radiotherapy for Breast Cancer (TARGIT-A) trial reported similar rates of local recurrence between patients receiving IORT and those receiving WBRT, with low risk of radiotherapy-related complications.
5 Radiotherapy raises concern for poor wound healing in the setting of increased complexity associated with OBCS. Studies report low rates of surgical site complications when IORT is performed as a boost during OBCS. 6 This study compares the surgical site complications associated with OBCS with IORT and OBCS with WBRT within 6 months of surgery.
Methods | This nested case-control study using data derived from a prospective database includes women undergoing OBCS for treatment of breast cancer between January 1, 2013, and July 31, 2015. Patients with unifocal tumors 3 cm or smaller, no clinical evidence of nodal disease, and lymphovascular invasion were offered partial mastectomy and IORT. The patients were divided into 2 groups: those treated with OBCS and IORT (IORT group) and those treated with OBCS with WBRT (WBRT group). Patients achieving margins less than 2 mm were offered reexcision.
Surgical site complications were evaluated. The study was approved by the Benaroya Research Institute Institutional Review Board, which waived patient consent. Continuous variables were compared using 2-tailed t tests and categorical data were compared using χ 2 tests. P < .05 was considered significant. Logistic regression was performed using statistical software (MedCalc, version 12.7.5; MedCalc Software bvba). In the treatment of many cancers, radiation after limited surgery can offer similar outcomes to more extensive surgery alone. Mischaracterization of the breast conservation data has allowed physicians and patients to see mastectomy and even contralateral prophylactic mastectomy as reasonable treatment options for young women with early-stage breast cancer.
1 As both a radiation oncologist and young breast cancer survivor, I have seen young patients with breast cancer (and some physicians) suggest that extensive surgery will result in better outcomes. 2 The higher local recurrence rates seen in those who undergo breast conservation surgery from the seminal trials comparing breast conservation to mastectomy is often cited, despite the fact that such women have similar disease-free and overall survival rates.
3 What is hardly considered is the minimal role systemic therapy and targeted agents had at that time. Many young women will require systemic therapy, as they are more likely to have biologically unfavorable cancers. Furthermore, there is some thought that women may be able to avoid radiation if they undergo a mastectomy. Fear of radiation therapy is palpable among patients and physicians, despite the fact that it is something we are so intricately associated with in our daily lives. With the release of the newest postmastectomy radiation guidelines, which discuss consideration of radiation for any node-positive disease, more women will find that they will benefit from adjuvant radiation whether or not they have had a mastectomy.
Finally, many young patients do not fully understand the implications of their choice to have mastectomy and reconstruction. Compared with breast conserving surgery, mastectomy and reconstruction surgeries require additional time for healing, can cause a prolonged period of pain and discomfort if expanders are in place, can possibly result in infection and secondary malignancy, 4 and can delay time to initiation of adjuvant oncologic therapy. Unfortunately, the current payment model incentivizes mastectomy and reconstruction over breast conservation surgery, which can be a motivating factor for some. As physicians and as patients, we can no longer let ourselves be controlled by fear. Rather, we should focus our efforts on improving outcomes for young patients by including and not excluding them from clinical trials, as they have the most to benefit from advancements in care.
